We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRAY icon
626
Dentsply Sirona
XRAY
$2.7B
$398K 0.05%
+14,718
New +$376K
PK icon
627
Park Hotels & Resorts
PK
$3.06B
$396K 0.05%
28,094
-55,808
-67% -$813K
REYN icon
628
Reynolds Consumer Products
REYN
$5.44B
$395K 0.05%
12,690
+875
+7% +$25.9K
XPO icon
629
XPO
XPO
$24B
$394K 0.05%
3,667
-2,851
-44% -$319K
SU icon
630
Suncor Energy
SU
$75.4B
$394K 0.05%
10,673
+1,636
+18% +$63.2K
PII icon
631
Polaris
PII
$4.07B
$392K 0.05%
+4,708
New +$382K
DORM icon
632
Dorman Products
DORM
$4.28B
$391K 0.05%
+3,454
New +$363K
B
633
Barrick Mining
B
$61.5B
$389K 0.05%
19,558
-22,407
-53% -$427K
ULS icon
634
UL Solutions
ULS
$18.5B
$384K 0.05%
+7,797
New +$380K
SYY icon
635
Sysco
SYY
$40.7B
$383K 0.05%
+4,910
New +$369K
TEN
636
Tsakos Energy Navigation Ltd
TEN
$1.18B
$382K 0.05%
15,216
+4,702
+45% +$119K
LBPH
637
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$381K 0.05%
+11,446
New +$394K
RYZ
638
Ryerson Holding Corp
RYZ
$1.61B
$381K 0.05%
19,129
-17,600
-48% -$356K
PSA icon
639
Public Storage
PSA
$61.7B
$381K 0.05%
1,046
+343
+49% +$111K
SD icon
640
SandRidge Energy
SD
$485M
$380K 0.05%
+31,059
New +$397K
BGC icon
641
BGC Group
BGC
$5.73B
$379K 0.05%
+41,294
New +$386K
DHIL
642
DELISTED
Diamond Hill
DHIL
$377K 0.05%
2,335
-11
-0.5% -$1.69K
ITT icon
643
ITT
ITT
$17.8B
$377K 0.05%
+2,519
New +$343K
QXO
644
QXO Inc
QXO
$14.8B
$376K 0.05%
+23,836
New +$695K
INVX
645
Innovex International
INVX
$1.79B
$374K 0.04%
25,458
-7,035
-22% -$113K
THRY icon
646
Thryv Holdings
THRY
$184M
$373K 0.04%
21,665
+4,632
+27% +$82.9K
SDRL icon
647
Seadrill
SDRL
$2.56B
$371K 0.04%
9,347
-3,397
-27% -$156K
FIZZ icon
648
National Beverage
FIZZ
$3.05B
$369K 0.04%
+7,852
New +$373K
ACCD
649
DELISTED
Accolade Inc
ACCD
$368K 0.04%
95,704
+37,152
+63% +$146K
MKSI icon
650
MKS Inc
MKSI
$19.3B
$368K 0.04%
+3,382
New +$402K
24 25
26
27 28

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.